Veltuzumab (IMMU-106) is a humanized anti-CD20 моноклональный антитело. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi клетка line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL).
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.